CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
The new facility is expected to significantly improve access to high-quality medical services for patients across Gujarat and neighbouring regions
This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
The national platform brought together healthcare professionals, patient advocates, and stakeholders
Subscribe To Our Newsletter & Stay Updated
